Document Detail

Successful Use of Low Molecular Weight Heparin in Intracardiac Thrombus of an Extremely Low Birth Weight Infant.
MedLine Citation:
PMID:  22798281     Owner:  NLM     Status:  Publisher    
The sick premature infants have high risk for thrombosis. Although therapeutic options include close observation, anticoagulation, thrombolytic therapy, and thrombectomy, guidelines for the management of neonatal arterial and venous thrombosis vary greatly among different centers. The authors report their experience using low molecular weight heparin (enoxaparin), with safe and successful resolution of right atrial thrombus, in an extremely low birth weight infant.
Ji-Hye Shin; Gee-Na Kim; Hong-Ryang Kil; Mea-Young Chang
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-15
Journal Detail:
Title:  Indian journal of pediatrics     Volume:  -     ISSN:  0973-7693     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417442     Medline TA:  Indian J Pediatr     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Pediatrics, School of Medicine, Chungnam National University, 282 Munwharo, Jung-gu, Daejeon, 301-721, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Does a Written Asthma Action Plan Reduce Unscheduled Doctor Visits in Children?
Next Document:  Cystic Fibrosis Presenting with Neonatal Cholestasis Simulating Biliary Atresia in a Patient with a ...